Magouliotis, D.E.; Karamolegkou, A.P.; Zotos, P.-A.; Tatsios, E.; Samara, A.A.; Alexopoulou, D.; Koutsougianni, F.; Sakellaridis, N.; Zacharoulis, D.; Dimas, K.
Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. Medicina 2022, 58, 1663.
https://doi.org/10.3390/medicina58111663
AMA Style
Magouliotis DE, Karamolegkou AP, Zotos P-A, Tatsios E, Samara AA, Alexopoulou D, Koutsougianni F, Sakellaridis N, Zacharoulis D, Dimas K.
Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. Medicina. 2022; 58(11):1663.
https://doi.org/10.3390/medicina58111663
Chicago/Turabian Style
Magouliotis, Dimitrios E., Anna P. Karamolegkou, Prokopis-Andreas Zotos, Evangelos Tatsios, Athina A. Samara, Dimitra Alexopoulou, Fani Koutsougianni, Nikos Sakellaridis, Dimitris Zacharoulis, and Konstantinos Dimas.
2022. "Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer" Medicina 58, no. 11: 1663.
https://doi.org/10.3390/medicina58111663
APA Style
Magouliotis, D. E., Karamolegkou, A. P., Zotos, P.-A., Tatsios, E., Samara, A. A., Alexopoulou, D., Koutsougianni, F., Sakellaridis, N., Zacharoulis, D., & Dimas, K.
(2022). Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer. Medicina, 58(11), 1663.
https://doi.org/10.3390/medicina58111663
